145 related articles for article (PubMed ID: 34727689)
1. Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.
Prakash M; Itoh Y; Fujiwara Y; Takahashi Y; Takada Y; Mellini P; Elboray EE; Terao M; Yamashita Y; Yamamoto C; Yamaguchi T; Kotoku M; Kitao Y; Singh R; Roy R; Obika S; Oba M; Wang DO; Suzuki T
J Med Chem; 2021 Nov; 64(21):15810-15824. PubMed ID: 34727689
[TBL] [Abstract][Full Text] [Related]
2. m
Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
[No Abstract] [Full Text] [Related]
3. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.
Huang Y; Yan J; Li Q; Li J; Gong S; Zhou H; Gan J; Jiang H; Jia GF; Luo C; Yang CG
Nucleic Acids Res; 2015 Jan; 43(1):373-84. PubMed ID: 25452335
[TBL] [Abstract][Full Text] [Related]
4. Identification of Specific
Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
[TBL] [Abstract][Full Text] [Related]
5. Structural characteristics of small-molecule inhibitors targeting
Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
[TBL] [Abstract][Full Text] [Related]
6. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
7. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
Su R; Dong L; Li Y; Gao M; Han L; Wunderlich M; Deng X; Li H; Huang Y; Gao L; Li C; Zhao Z; Robinson S; Tan B; Qing Y; Qin X; Prince E; Xie J; Qin H; Li W; Shen C; Sun J; Kulkarni P; Weng H; Huang H; Chen Z; Zhang B; Wu X; Olsen MJ; Müschen M; Marcucci G; Salgia R; Li L; Fathi AT; Li Z; Mulloy JC; Wei M; Horne D; Chen J
Cancer Cell; 2020 Jul; 38(1):79-96.e11. PubMed ID: 32531268
[TBL] [Abstract][Full Text] [Related]
8. m
Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.
Selberg S; Yu LY; Bondarenko O; Kankuri E; Seli N; Kovaleva V; Herodes K; Saarma M; Karelson M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926120
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors.
Shishodia S; Demetriades M; Zhang D; Tam NY; Maheswaran P; Clunie-O'Connor C; Tumber A; Leung IKH; Ng YM; Leissing TM; El-Sagheer AH; Salah E; Brown T; Aik WS; McDonough MA; Schofield CJ
J Med Chem; 2021 Nov; 64(22):16609-16625. PubMed ID: 34762429
[TBL] [Abstract][Full Text] [Related]
11. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
[TBL] [Abstract][Full Text] [Related]
12. Identification of nafamostat mesilate as an inhibitor of the fat mass and obesity-associated protein (FTO) demethylase activity.
Han X; Wang N; Li J; Wang Y; Wang R; Chang J
Chem Biol Interact; 2019 Jan; 297():80-84. PubMed ID: 30393114
[TBL] [Abstract][Full Text] [Related]
13. Rational Design and Optimization of m
Huff S; Kummetha IR; Zhang L; Wang L; Bray W; Yin J; Kelley V; Wang Y; Rana TM
J Med Chem; 2022 Aug; 65(16):10920-10937. PubMed ID: 35939803
[TBL] [Abstract][Full Text] [Related]
14. A photo-responsive chemical modulation of m
Lan L; Sun YJ; Liu L; Cheng L
Chem Commun (Camb); 2021 Oct; 57(81):10548-10551. PubMed ID: 34553720
[TBL] [Abstract][Full Text] [Related]
15. Autophagy of the m
Cui YH; Yang S; Wei J; Shea CR; Zhong W; Wang F; Shah P; Kibriya MG; Cui X; Ahsan H; He C; He YY
Nat Commun; 2021 Apr; 12(1):2183. PubMed ID: 33846348
[TBL] [Abstract][Full Text] [Related]
16. The N
Strick A; von Hagen F; Gundert L; Klümper N; Tolkach Y; Schmidt D; Kristiansen G; Toma M; Ritter M; Ellinger J
BJU Int; 2020 Apr; 125(4):617-624. PubMed ID: 31985880
[TBL] [Abstract][Full Text] [Related]
17. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.
Jia G; Fu Y; Zhao X; Dai Q; Zheng G; Yang Y; Yi C; Lindahl T; Pan T; Yang YG; He C
Nat Chem Biol; 2011 Oct; 7(12):885-7. PubMed ID: 22002720
[TBL] [Abstract][Full Text] [Related]
19. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
Shen F; Huang W; Huang JT; Xiong J; Yang Y; Wu K; Jia GF; Chen J; Feng YQ; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2015 Jan; 100(1):E148-54. PubMed ID: 25303482
[TBL] [Abstract][Full Text] [Related]
20. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
